Deutsche Bank AG Reaffirms “Buy” Rating for BTG plc (BTG)
BTG plc (LON:BTG)‘s stock had its “buy” rating reissued by equities research analysts at Deutsche Bank AG in a research report issued on Friday.
Several other research analysts have also recently commented on the stock. Stifel Nicolaus cut shares of BTG plc to a “hold” rating in a report on Thursday, July 14th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a GBX 790 ($10.31) price target on shares of BTG plc in a research note on Tuesday, August 16th. Numis Securities Ltd reiterated a “hold” rating and issued a GBX 737 ($9.62) price target on shares of BTG plc in a research note on Thursday, July 14th. Finally, Jefferies Group increased their price target on shares of BTG plc from GBX 840 ($10.96) to GBX 860 ($11.23) and gave the company a “buy” rating in a research note on Wednesday, June 29th. Four analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. BTG plc has an average rating of “Buy” and a consensus target price of GBX 799.57 ($10.44).
Shares of BTG plc (LON:BTG) opened at 684.00 on Friday. The company has a 50-day moving average of GBX 627.97 and a 200-day moving average of GBX 640.80. BTG plc has a 1-year low of GBX 504.00 and a 1-year high of GBX 739.50. The company’s market cap is GBX 2.62 billion.
In other news, insider Soderstrom,Rolf sold 74,327 shares of the firm’s stock in a transaction dated Thursday, July 21st. The shares were sold at an average price of GBX 676 ($8.82), for a total transaction of £502,450.52 ($655,855.01).
BTG plc Company Profile
BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing.
Receive News & Ratings for BTG plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related companies with MarketBeat.com's FREE daily email newsletter.